Search research articles
Contact Us
Filters
Showing results (71-80 of 157) with videos related to
Page
of 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11
Patsy G Oliver, Albert F LoBuglio, Kurt R Zinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model
Donald J Buchsbaum, Tong Zhou, William E Grizzle, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
December 9, 2004
Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells
J Pablo Arnoletti, Donald J Buchsbaum, Zhi-qiang Huang, et al.
Cancer Letters
|
January 4, 2017
SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells
Yonghe Li, Patsy G Oliver, Wenyan Lu, et al.
Breast Cancer Research and Treatment
|
September 15, 2011
Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity
Angelina I Londoño-Joshi, Patsy G Oliver, Yufeng Li, et al.
Cancer Letters
|
March 27, 2018
Retraction notice to "SRI36160 is a specific inhibitor of Wnt/<beta>-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41-48]
Yonghe Li, Patsy G Oliver, Wenyan Lu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 2004
Anti-EGFR-mediated radiosensitization as a result of augmented EGFR expression
James A Bonner, Donald J Buchsbaum, Suzanne M Russo, et al.
Nuclear Medicine and Biology
|
January 21, 2017
B7-H3-targeted <sup>212</sup>Pb radioimmunotherapy of ovarian cancer in preclinical models
Benjamin B Kasten, Rebecca C Arend, Ashwini A Katre, et al.
Molecular Cancer Therapeutics
|
December 17, 2002
Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation
Carmelo Blanquicett, G Yancey Gillespie, L Burt Nabors, et al.
Journal of Medicinal Chemistry
|
February 24, 2017
Retraction of "Design and Synthesis of Novel Cyclic Amine Benzimidazoles for the Treatment of Pancreatic Cancer"
Vibha Pathak, Corinne E Augelli-Szafran, Han-Xun Wei, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 157) with videos related to
Sort By:
Page
of 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11
Patsy G Oliver, Albert F LoBuglio, Kurt R Zinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model
Donald J Buchsbaum, Tong Zhou, William E Grizzle, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
December 9, 2004
Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells
J Pablo Arnoletti, Donald J Buchsbaum, Zhi-qiang Huang, et al.
Cancer Letters
|
January 4, 2017
SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells
Yonghe Li, Patsy G Oliver, Wenyan Lu, et al.
Breast Cancer Research and Treatment
|
September 15, 2011
Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity
Angelina I Londoño-Joshi, Patsy G Oliver, Yufeng Li, et al.
Cancer Letters
|
March 27, 2018
Retraction notice to "SRI36160 is a specific inhibitor of Wnt/<beta>-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41-48]
Yonghe Li, Patsy G Oliver, Wenyan Lu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 2004
Anti-EGFR-mediated radiosensitization as a result of augmented EGFR expression
James A Bonner, Donald J Buchsbaum, Suzanne M Russo, et al.
Nuclear Medicine and Biology
|
January 21, 2017
B7-H3-targeted <sup>212</sup>Pb radioimmunotherapy of ovarian cancer in preclinical models
Benjamin B Kasten, Rebecca C Arend, Ashwini A Katre, et al.
Molecular Cancer Therapeutics
|
December 17, 2002
Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation
Carmelo Blanquicett, G Yancey Gillespie, L Burt Nabors, et al.
Journal of Medicinal Chemistry
|
February 24, 2017
Retraction of "Design and Synthesis of Novel Cyclic Amine Benzimidazoles for the Treatment of Pancreatic Cancer"
Vibha Pathak, Corinne E Augelli-Szafran, Han-Xun Wei, et al.
Page
of 16